How can we improve patients’ access to new drugs under uncertainties?: South Korea’s experience with risk sharing arrangements

doi:10.21203/rs.3.rs-63507/v1

How can we improve patients’ access to new drugs under uncertainties?: South Korea’s experience with risk sharing arrangements

2020 · doi:10.21203/rs.3.rs-63507/v1

preprint OA: closed

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher →

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc: last seen: 2026-05-19T01:45:01.086888+00:00